Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 141

Similar articles for PubMed (Select 23404653)

1.

The inverse relation of HDL anti-oxidative functionality with serum amyloid a is lost in metabolic syndrome subjects.

Dullaart RP, de Boer JF, Annema W, Tietge UJ.

Obesity (Silver Spring). 2013 Feb;21(2):361-6. doi: 10.1002/oby.20058.

PMID:
23404653
2.

High sensitive C-reactive protein and serum amyloid A are inversely related to serum bilirubin: effect-modification by metabolic syndrome.

Deetman PE, Bakker SJ, Dullaart RP.

Cardiovasc Diabetol. 2013 Nov 9;12:166. doi: 10.1186/1475-2840-12-166.

3.

Lower serum paraoxonase-1 activity is related to higher serum amyloid a levels in metabolic syndrome.

Kappelle PJ, Bijzet J, Hazenberg BP, Dullaart RP.

Arch Med Res. 2011 Apr;42(3):219-25. doi: 10.1016/j.arcmed.2011.05.002.

PMID:
21722818
4.

The positive relationship of serum paraoxonase-1 activity with apolipoprotein E is abrogated in metabolic syndrome.

Dullaart RP, Kwakernaak AJ, Dallinga-Thie GM.

Atherosclerosis. 2013 Sep;230(1):6-11. doi: 10.1016/j.atherosclerosis.2013.06.019. Epub 2013 Jul 1.

PMID:
23958245
5.

High-density lipoprotein associated factors apoA-I and serum amyloid A in Chinese non-diabetic patients with coronary heart disease.

Chen GL, Liu LW, Xie S, Liu H, Liu YQ, Li YS.

Chin Med J (Engl). 2010 Mar 20;123(6):658-63.

PMID:
20368082
6.

Remnant-like particle cholesterol and serum amyloid A-low-density lipoprotein levels in obese subjects with metabolic syndrome.

Kotani K, Asahara-Satoh N, Kato Y, Araki R, Himeno A, Yamakage H, Koyama K, Tanabe M, Oishi M, Okajima T, Shimatsu A; Japan Obesity and Metabolic Syndrome Study (JOMS) Group.

J Clin Lipidol. 2011 Sep-Oct;5(5):395-400. doi: 10.1016/j.jacl.2011.08.001. Epub 2011 Aug 12.

PMID:
21981841
7.

Fibroblast cholesterol efflux to plasma from metabolic syndrome subjects is not defective despite low high-density lipoprotein cholesterol.

Dullaart RP, Groen AK, Dallinga-Thie GM, de Vries R, Sluiter WJ, van Tol A.

Eur J Endocrinol. 2008 Jan;158(1):53-60. doi: 10.1530/EJE-07-0451.

8.

A novel oxidized low-density lipoprotein marker, serum amyloid A-LDL, is associated with obesity and the metabolic syndrome.

Kotani K, Satoh N, Kato Y, Araki R, Koyama K, Okajima T, Tanabe M, Oishi M, Yamakage H, Yamada K, Hattori M, Shimatsu A; Japan Obesity and Metabolic Syndrome Study Group.

Atherosclerosis. 2009 Jun;204(2):526-31. doi: 10.1016/j.atherosclerosis.2008.09.017. Epub 2008 Sep 27.

PMID:
19007930
9.

Effect of three consecutive meals on the physicochemical properties of HDL and LDL in individuals with the metabolic syndrome and patients with type 2 diabetes.

Scheffer PG, Tushuizen ME, Vermue HP, Schindhelm RK, Rustemeijer C, Diamant M.

Eur J Clin Nutr. 2011 Nov;65(11):1242-9. doi: 10.1038/ejcn.2011.114. Epub 2011 Jun 29.

PMID:
21712838
11.

The association between adiponectin, HDL-cholesterol and α1-antitrypsin-LDL in female subjects without metabolic syndrome.

Kotani K, Yamada T, Taniguchi N.

Lipids Health Dis. 2010 Dec 30;9:147. doi: 10.1186/1476-511X-9-147.

12.

Serum amyloid A is found on ApoB-containing lipoproteins in obese humans with diabetes.

Jahangiri A, Wilson PG, Hou T, Brown A, King VL, Tannock LR.

Obesity (Silver Spring). 2013 May;21(5):993-6. doi: 10.1002/oby.20126.

13.

Serum amyloid A is independently related to apolipoprotein A-I but not to HDL-cholesterol in patients with angina pectoris.

Korita I, Bulo A, Langlois MR, Verhoye E, Blaton V.

Clin Biochem. 2013 Nov;46(16-17):1660-3. doi: 10.1016/j.clinbiochem.2013.07.021. Epub 2013 Aug 27.

PMID:
23994331
15.

Serum amyloid A is independently associated with metabolic risk factors but not with early atherosclerosis: the Cardiovascular Risk in Young Finns Study.

Jylhävä J, Haarala A, Eklund C, Pertovaara M, Kähönen M, Hutri-Kähönen N, Levula M, Lehtimäki T, Huupponen R, Jula A, Juonala M, Viikari J, Raitakari O, Hurme M.

J Intern Med. 2009 Sep;266(3):286-95. doi: 10.1111/j.1365-2796.2009.02120.x.

PMID:
19702793
16.

Apolipoproteins A-I, B, and C-III in young adult Cherokee with metabolic syndrome with or without type 2 diabetes.

Wang W, Khan S, Blackett P, Alaupovic P, Lee E.

J Clin Lipidol. 2013 Jan-Feb;7(1):38-42. doi: 10.1016/j.jacl.2012.06.007. Epub 2012 Jul 2.

17.

Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity.

Hansel B, Giral P, Nobecourt E, Chantepie S, Bruckert E, Chapman MJ, Kontush A.

J Clin Endocrinol Metab. 2004 Oct;89(10):4963-71.

PMID:
15472192
18.

Increased apolipoprotein E level and reduced high-density lipoprotein mean particle size associate with low high-density lipoprotein cholesterol and features of metabolic syndrome.

Söderlund S, Watanabe H, Ehnholm C, Jauhiainen M, Taskinen MR.

Metabolism. 2010 Oct;59(10):1502-9. doi: 10.1016/j.metabol.2010.01.015. Epub 2010 Mar 6.

PMID:
20206948
19.

Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis.

van Eijk IC, de Vries MK, Levels JH, Peters MJ, Huizer EE, Dijkmans BA, van der Horst-Bruinsma IE, Hazenberg BP, van de Stadt RJ, Wolbink GJ, Nurmohamed MT.

Arthritis Rheum. 2009 May;60(5):1324-30. doi: 10.1002/art.24492.

20.

Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men.

Gannagé-Yared MH, Khalife S, Semaan M, Fares F, Jambart S, Halaby G.

Eur J Endocrinol. 2006 Jul;155(1):167-76.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk